Validating the GTP‐cyclohydrolase 1‐feedback regulatory complex as a therapeutic target using biophysical and in vivo approaches

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|16|4146-4157

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.16, 2015-08, pp. : 4146-4157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence of a role for GTP cyclohydrolase‐1 in visceral pain

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 5, 2015-05 ,pp. : 656-662

John Wiley & Sons Inc

Access to resources Recommend Favorite

GTP cyclohydrolase 1 mutations and Parkinson's disease: New insights beyond DOPA‐responsive dystonia

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 910-910

John Wiley & Sons Inc

Access to resources Recommend Favorite

The GLP‐1 system as a therapeutic target

By Edwards Mark  

Annals of Medicine, Vol. 37, Iss. 5, 2005-09 ,pp. : 314-322

Informa Healthcare

Access to resources Recommend Favorite

High-density lipoprotein: therapeutic target, 1 year on

By Sirtori Cesare R  

Future Lipidology, Vol. 2, Iss. 1, 2007-02 ,pp. : 1-4

Future Medicine

Access to resources Recommend Favorite

TRPV1: A Potential Therapeutic Target for Myocardial Infarction?

By  

Cardiology, Vol. 136, Iss. 3, 2016-09 ,pp. : 156-156

Karger

Access to resources Recommend Favorite